Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies
Miriam Højholt Terkelsen, Ida Hyllen Klæstrup, Victor Schwartz Hvingelby, et al.
Journal of Parkinson s Disease (2022) Vol. 12, Iss. s1, pp. S149-S163
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Alpha Synuclein: Neurodegeneration and Inflammation
Gianluigi Forloni
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5914-5914
Open Access | Times Cited: 52
Causal relationship between immune cells and neurodegenerative diseases: a two-sample Mendelian randomisation study
Chao Tang, Xiaoyang Lei, Yaqi Ding, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 18
Innate immune activation in neurodegenerative diseases
Sergio Castro‐Gomez, Michael T. Heneka
Immunity (2024) Vol. 57, Iss. 4, pp. 790-814
Closed Access | Times Cited: 18
The immune system in Parkinson’s disease: what we know so far
Cintia Roodveldt, Liliana Bernardino, Özgür Öztop Çakmak, et al.
Brain (2024)
Open Access | Times Cited: 17
Role of NLRP3 Inflammasome in Parkinson’s Disease and Therapeutic Considerations
Linh Thi Nhat Nguyen, Hữu Đạt Nguyễn, Yun Joong Kim, et al.
Journal of Parkinson s Disease (2022) Vol. 12, Iss. 7, pp. 2117-2133
Open Access | Times Cited: 43
Peripheral inflammatory immune response differs among sporadic and familial Parkinson’s disease
Laura Muñoz‐Delgado, Daniel Macías‐García, María Teresa Periñán, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 27
Amyloid-β aggregates activate peripheral monocytes in mild cognitive impairment
Kristian Juul‐Madsen, Peter Parbo, Rola Ismail, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Gut microbiota and derived metabolomic profiling in glaucoma with progressive neurodegeneration
Yinglei Zhang, Xujiao Zhou, Yi Lu
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 28
Neutrophil-to-lymphocyte ratio and lymphocyte count reflect alterations in central neurodegeneration-associated proteins and clinical severity in Parkinson Disease patients
Piergiorgio Grillo, Giulia Maria Sancesario, Roberta Bovenzi, et al.
Parkinsonism & Related Disorders (2023) Vol. 112, pp. 105480-105480
Closed Access | Times Cited: 13
Association analysis of dopaminergic degeneration and the neutrophil-to-lymphocyte ratio in Parkinson’s disease
Fengjiao Zhang, Bin Chen, Wenhua Ren, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 5
PARK7/DJ-1 deficiency impairs microglial activation in response to LPS-induced inflammation
Frida Lind‐Holm Mogensen, Carole Sousa, Corrado Ameli, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 4
Microbiota–neuroepithelial signalling across the gut–brain axis
Takahiro E. Ohara, Elaine Y. Hsiao
Nature Reviews Microbiology (2025)
Closed Access
Revisiting the advance of age-dependent α-synuclein propagation and aggregation
Dong‐Yan Song, Jiayi Li
Ageing and Neurodegenerative Diseases (2025) Vol. 5, Iss. 1
Open Access
Investigating cuproptosis and mitochondrial dysfunction in brain cells: uncovering novel mechanisms and biomarkers for Parkinson’s disease
Q. Li, Dongliang Li, Yinghong Li, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 3
Closed Access
Gut microbiota-induced CXCL1 elevation triggers early neuroinflammation in the substantia nigra of Parkinsonian mice
Xizhen Ma, Leilei Chen, Le Qu, et al.
Acta Pharmacologica Sinica (2023) Vol. 45, Iss. 1, pp. 52-65
Closed Access | Times Cited: 11
Cytokine activity in Parkinson’s disease
Nicolas Dzamko
Neuronal Signaling (2023) Vol. 7, Iss. 4
Open Access | Times Cited: 11
Experimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson’s Disease
Jasna Šaponjić, Rebeca Mejı́as, Neda Nikolovski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4330-4330
Open Access | Times Cited: 3
Infections in the Etiology of Parkinson’s Disease and Synucleinopathies: A Renewed Perspective, Mechanistic Insights, and Therapeutic Implications
Gabriela Mercado, Christopher Kaeufer, Franziska Richter, et al.
Journal of Parkinson s Disease (2024), pp. 1-29
Open Access | Times Cited: 3
A functional role for alpha-synuclein in neuroimmune responses
Dustin L. Heiden, Brendan Monogue, Muhammad Ali, et al.
Journal of Neuroimmunology (2023) Vol. 376, pp. 578047-578047
Open Access | Times Cited: 8
Nigrostriatal Inflammation Is Associated with Nonmotor Symptoms in an Experimental Model of Prodromal Parkinson’s Disease
Bruna da Silva Oliveira, Eliana Cristina de Brito Toscano, Larissa Katharina Sabino Abreu, et al.
Neuroscience (2024) Vol. 549, pp. 65-75
Open Access | Times Cited: 2
Gastrointestinal Dysfunction Bears on the Clinical‐Biological Profile of Parkinson's Disease
Jacopo Bissacco, Roberta Bovenzi, Matteo Conti, et al.
Movement Disorders Clinical Practice (2024)
Open Access | Times Cited: 2
Modeling Parkinson’s disease in LRRK2 rodents
Chiara Domenicale, Stefano Magnabosco, Michele Morari
Neuronal Signaling (2023) Vol. 7, Iss. 3
Open Access | Times Cited: 5
Relevance of tissue-resident memory CD8 T cells in the onset of Parkinson’s disease and examination of its possible etiologies: infectious or autoimmune?
Oriol de Fàbregues, María Clara Sellés, David Ramos-Vicente, et al.
Neurobiology of Disease (2023) Vol. 187, pp. 106308-106308
Open Access | Times Cited: 5
Unlocking the Potential of Low-Molecular-Weight (Poly)phenol Metabolites: Protectors at the Blood-Brain Barrier Frontier
Daniela Marques, Diogo Moura-Louro, Inês P. Silva, et al.
Neurochemistry International (2024) Vol. 179, pp. 105836-105836
Open Access | Times Cited: 1
Neuroinflammation, immune response and α-synuclein pathology: how animal models are helping us to connect dots
Tiziano Balzano, Noelia Esteban-García, Javier Blesa
Expert Opinion on Drug Discovery (2022) Vol. 18, Iss. 1, pp. 13-23
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top